DK1448181T3 - Farmaceutisk præparat som omfatter en kombination af metformin og en 4-oxobutansyre og anvendelse deraf til behandling af diabetes - Google Patents
Farmaceutisk præparat som omfatter en kombination af metformin og en 4-oxobutansyre og anvendelse deraf til behandling af diabetesInfo
- Publication number
- DK1448181T3 DK1448181T3 DK02787576T DK02787576T DK1448181T3 DK 1448181 T3 DK1448181 T3 DK 1448181T3 DK 02787576 T DK02787576 T DK 02787576T DK 02787576 T DK02787576 T DK 02787576T DK 1448181 T3 DK1448181 T3 DK 1448181T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- aryl
- metformin
- diabetes
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0115398A FR2832633B1 (fr) | 2001-11-28 | 2001-11-28 | Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1448181T3 true DK1448181T3 (da) | 2006-09-04 |
Family
ID=8869889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02787576T DK1448181T3 (da) | 2001-11-28 | 2002-11-06 | Farmaceutisk præparat som omfatter en kombination af metformin og en 4-oxobutansyre og anvendelse deraf til behandling af diabetes |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050020609A1 (da) |
| EP (1) | EP1448181B1 (da) |
| JP (1) | JP2005515984A (da) |
| KR (1) | KR20040058266A (da) |
| CN (1) | CN1592615A (da) |
| AT (1) | ATE327746T1 (da) |
| AU (1) | AU2002351848A1 (da) |
| BR (1) | BR0214487A (da) |
| CA (1) | CA2468280A1 (da) |
| CY (1) | CY1105165T1 (da) |
| DE (1) | DE60211938T2 (da) |
| DK (1) | DK1448181T3 (da) |
| ES (1) | ES2266605T3 (da) |
| FR (1) | FR2832633B1 (da) |
| HU (1) | HUP0402241A2 (da) |
| MX (1) | MXPA04005033A (da) |
| PL (1) | PL369894A1 (da) |
| PT (1) | PT1448181E (da) |
| RU (1) | RU2004119817A (da) |
| TW (1) | TW200300341A (da) |
| WO (1) | WO2003045368A1 (da) |
| ZA (1) | ZA200405021B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005117855A1 (ja) * | 2004-06-04 | 2005-12-15 | Kowa Company., Ltd. | 糖尿病の予防または治療のための薬剤 |
| EP1792580A1 (en) | 2005-09-27 | 2007-06-06 | Ziterion GmbH | Two-part dental implants made of biocompatible ceramics |
| EP1967157A1 (en) | 2007-03-05 | 2008-09-10 | Ziterion GmbH | Hybrid two-part dental implant |
| EP2106767A1 (en) | 2008-03-31 | 2009-10-07 | Ziterion GmbH | Two-part dental implant |
| GB201004058D0 (en) * | 2010-03-11 | 2010-04-28 | Consiglio Nazionale Ricerche | Diagnostic assay for obesity and related disorders |
| WO2020064857A1 (en) * | 2018-09-28 | 2020-04-02 | Société des Produits Nestlé S.A. | Compounds that enhance the action of metformin |
| CN114349665B (zh) * | 2021-11-30 | 2023-06-09 | 潍坊博创国际生物医药研究院 | 二甲双胍焦谷氨酸晶体及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5863915A (en) * | 1996-05-15 | 1999-01-26 | Bayer Corporation | Substituted 4-arylbutyric acid derivatives as matrix metalloprotease |
| FR2752422B1 (fr) * | 1996-08-16 | 1998-11-06 | Lipha | Composition pharmaceutique contenant des acides 4-oxo-butanoiques |
| US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
| GB9922710D0 (en) * | 1999-09-24 | 1999-11-24 | Bayer Ag | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis |
| US6296874B1 (en) * | 2000-05-01 | 2001-10-02 | Aeropharm Technology Incorporated | Core formulation comprising troglitazone and abiguanide |
-
2001
- 2001-11-28 FR FR0115398A patent/FR2832633B1/fr not_active Expired - Fee Related
-
2002
- 2002-11-06 DK DK02787576T patent/DK1448181T3/da active
- 2002-11-06 RU RU2004119817/15A patent/RU2004119817A/ru not_active Application Discontinuation
- 2002-11-06 PL PL02369894A patent/PL369894A1/xx not_active Application Discontinuation
- 2002-11-06 CN CNA028228375A patent/CN1592615A/zh active Pending
- 2002-11-06 AU AU2002351848A patent/AU2002351848A1/en not_active Abandoned
- 2002-11-06 PT PT02787576T patent/PT1448181E/pt unknown
- 2002-11-06 EP EP02787576A patent/EP1448181B1/en not_active Expired - Lifetime
- 2002-11-06 AT AT02787576T patent/ATE327746T1/de not_active IP Right Cessation
- 2002-11-06 BR BR0214487-5A patent/BR0214487A/pt not_active IP Right Cessation
- 2002-11-06 MX MXPA04005033A patent/MXPA04005033A/es not_active Application Discontinuation
- 2002-11-06 ES ES02787576T patent/ES2266605T3/es not_active Expired - Lifetime
- 2002-11-06 US US10/497,145 patent/US20050020609A1/en not_active Abandoned
- 2002-11-06 DE DE60211938T patent/DE60211938T2/de not_active Expired - Fee Related
- 2002-11-06 CA CA002468280A patent/CA2468280A1/en not_active Abandoned
- 2002-11-06 JP JP2003546870A patent/JP2005515984A/ja active Pending
- 2002-11-06 WO PCT/EP2002/012355 patent/WO2003045368A1/en active IP Right Grant
- 2002-11-06 KR KR10-2004-7006791A patent/KR20040058266A/ko not_active Application Discontinuation
- 2002-11-06 HU HU0402241A patent/HUP0402241A2/hu unknown
- 2002-11-22 TW TW091134094A patent/TW200300341A/zh unknown
-
2004
- 2004-06-24 ZA ZA200405021A patent/ZA200405021B/en unknown
-
2006
- 2006-08-23 CY CY20061101178T patent/CY1105165T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0214487A (pt) | 2004-10-19 |
| HUP0402241A2 (hu) | 2005-02-28 |
| RU2004119817A (ru) | 2005-04-20 |
| DE60211938T2 (de) | 2007-05-24 |
| EP1448181A1 (en) | 2004-08-25 |
| CA2468280A1 (en) | 2003-06-05 |
| MXPA04005033A (es) | 2004-08-11 |
| KR20040058266A (ko) | 2004-07-03 |
| EP1448181B1 (en) | 2006-05-31 |
| PL369894A1 (en) | 2005-05-02 |
| CN1592615A (zh) | 2005-03-09 |
| FR2832633A1 (fr) | 2003-05-30 |
| JP2005515984A (ja) | 2005-06-02 |
| ATE327746T1 (de) | 2006-06-15 |
| CY1105165T1 (el) | 2010-03-03 |
| AU2002351848A1 (en) | 2003-06-10 |
| DE60211938D1 (de) | 2006-07-06 |
| ZA200405021B (en) | 2005-05-30 |
| PT1448181E (pt) | 2006-10-31 |
| ES2266605T3 (es) | 2007-03-01 |
| WO2003045368A1 (en) | 2003-06-05 |
| US20050020609A1 (en) | 2005-01-27 |
| FR2832633B1 (fr) | 2004-09-24 |
| TW200300341A (en) | 2003-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1263722T3 (da) | Farmaceutiske sammensætninger, som indeholder azetidinderivat, nye azetidinderivater og fremstilling deraf | |
| AR036045A1 (es) | Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, su empleo para la preparacion de un medicamento, asi como composiciones farmaceuticas que las contienen | |
| RU2006138019A (ru) | Улучшенный способ отбеливания зубов | |
| DE602005007339D1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| AR042658A1 (es) | Derivados de 1,5-diaril-pirrol-3-carboxamida y su uso como moduladores de receptores canabinoides | |
| NO20030619L (no) | Prolinderivater og anvendelse derav som legemidler | |
| WO2003024955A3 (en) | Small molecule inhibitors of caspases | |
| RS24604A (en) | Herbicides containing substituted thien- 3-yl-sulfonylamino (thio)carbonyl- triazolin(thi)one | |
| ATE355075T1 (de) | Behandlung der glykogenspeicherkrankheit typ ii | |
| DK1448181T3 (da) | Farmaceutisk præparat som omfatter en kombination af metformin og en 4-oxobutansyre og anvendelse deraf til behandling af diabetes | |
| EP1314719A4 (en) | BENZOIC ACID DERIVATIVES AND MEDICAMENTS HAVING THE SAME AS ACTIVE INGREDIENT | |
| ATE364586T1 (de) | Steigerung der wirksamkeit von wirkstoffen durch micellare zubereitung mit retinolderivaten | |
| SE0002476D0 (sv) | New compounds | |
| DK2316454T3 (da) | Doseringsform indeholdende pantoprazol som aktiv bestanddel | |
| EA200701805A1 (ru) | Состав аэрозоля для дозирующих ингаляторов под давлением | |
| DE502004005055D1 (de) | Oxaliplatinlösungskonzentrate | |
| FR2848851B1 (fr) | Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues | |
| EA200300272A1 (ru) | Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их | |
| DE60230629D1 (de) | Verwendung von 2,5-dihydroxybenzolsulfonsäure-derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion | |
| DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| BRPI0406840A (pt) | Derivados de acil-fenil-uréia substituìdos por carbonilamino, processos para a sua preparação e sua aplicação | |
| NO20050834L (no) | Ny indolinforbindelse og medisinsk anvendelse derav | |
| ATE366234T1 (de) | Neue substanz mit antitumorwirkung/entzündungshemmender wirkung | |
| SE0501490L (sv) | En sammansättning för behanding av ytor och användning därav | |
| RU2003114406A (ru) | Витаминная композиция |